查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1599694

微型RNA市場：按檢測類型、產品類型、服務類型、應用分類 - 2025-2030 年全球預測

microRNA Market by Assay Type (Chemiluminescent Assays, Colorimetric Assays, Fluorescent Assays), Product (Consumables, Instruments), Services Type, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年微型RNA市值為21.2億美元，預計2024年將達到27.2億美元，複合年成長率為28.84%，到2030年將達到125.1億美元。

微型RNA（miRNA）是一類非編碼小RNA分子，在基因表現調控中發揮重要作用，在發育、分化、凋亡、代謝等多種生物過程中發揮重要作用。 miRNA研究的需求主要源自於其在疾病診斷、治療和個人化醫療方面的潛在應用，例如腫瘤學、心血管疾病和神經退化性疾病。 miRNA 的最終用途包括製藥公司、學術研究機構和診斷中心。影響 miRNA 市場的關鍵成長要素包括下一代定序技術的進步、慢性病盛行率的增加以及基因組學研究資金的增加。最新的機會在於人工智慧和 miRNA 的整合，以增強生物標記的發現和基於 miRNA 的療法的開發，特別是針對遺傳性疾病和癌症。為了利用這些機會，企業應該投資奈米技術等創新輸送系統的研發，並與學術機構合作加速探索階段。

主要市場統計
基準年[2023] 21.2億美元
預測年份 [2024] 27.2億美元
預測年份 [2030] 125.1億美元
複合年成長率（%） 28.84%

然而，市場面臨一些限制，例如 miRNA 生物合成的複雜性、治療傳遞的挑戰和嚴格的法律規範。樣品處理和資料變異等技術問題也構成了重大挑戰。我們可以透過開發用於全面 miRNA 分析的強大多重技術、改進資料分析計算工具以及提高預測模型的準確性來推動創新。相關人員之間的合作研究可以進一步擴大研究成果並縮短新開發產品的上市時間。 miRNA 領域是動態且不斷發展的，需要靈活的策略以及對監管變化和技術進步的適應性。持續監控監管環境並培養公私夥伴關係關係有助於克服成長挑戰。為了保持競爭力，公司應專注於建立個人化醫療解決方案並擴大非侵入性診斷的檢測開發。部署轉化研究來填補臨床空白對於實現長期市場潛力和以患者為中心的結果也至關重要。

市場動態：揭示快速發展的微型RNA市場的關鍵市場洞察

供需的動態交互作用正在改變微型RNA市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 慢性病盛行率上升，癌症患者數量增加
    • 微型RNA在多種疾病診斷中的重要性日益增加
    • 探索微型RNA潛力的全球研究活動不斷增加
  • 市場限制因素
    • 與微型RNA套件和其他產品相關的高成本
  • 市場機會
    • 用於疾病相關分析應用的微型RNA工具的出現
    • 基因組研究的進展以及支持研究活動的新工具的採用
  • 市場問題
    • 微型RNA安全性和毒性問題

波特五力：駕馭微型RNA市場的策略工具

波特的五力架構是了解微型RNA市場競爭格局的重要工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解微型RNA市場的外部影響

外部宏觀環境因素在塑造微型RNA市場的績效動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析：了解微型RNA市場的競爭格局

對微型RNA市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣： 微型RNA市場供應商績效評估

FPNV定位矩陣是評估微型RNA市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：繪製微型RNA市場的成功之路

微型RNA市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1.市場滲透率：對當前市場環境的詳細審查，主要企業的廣泛資料，評估他們在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：全面分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 慢性病發生率和癌症病例數增加
      • 微型RNA在各種疾病診斷中的重要性日益增加
      • 擴大研究活動，在全球探索微型RNA的潛力
    • 抑制因素
      • 與微型RNA套件和其他產品相關的高成本
    • 機會
      • 用於疾病相關分析應用的新型微型RNA工具
      • 基因組研究的進展和支持研究工作的新工具的引入
    • 任務
      • 微型RNA安全性和毒性問題
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章微型RNA市場：依檢測類型

  • 介紹
  • 化學冷光分析
  • 比色測定
  • 螢光測定
  • 免疫檢測
  • miRNA陣列
  • 次世代定序
  • 基於 PCR 的檢測

第 7 章微型RNA市場：依產品

  • 介紹
  • 消耗品
  • 裝置

第 8 章微型RNA市場：依服務型

  • 介紹
  • 功能研究服務
  • 微陣列服務

第 9 章微型RNA市場：依應用分類

  • 介紹
  • 癌症
  • 心血管疾病
  • 免疫疾病
  • 感染疾病
  • 神經系統疾病

第10章 美洲微型RNA市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太微型RNA市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲的微型RNA市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abcam PLC
  • Bio-Rad Laboratories, Inc.
  • Global Life Sciences Solutions USA LLC
  • HTG Molecular Diagnostics, Inc.
  • Illumina, Inc.
  • Integrated DNA Technologies, Inc
  • Lexogen GmbH
  • Meridian Bioscience Inc
  • New England Biolabs (UK) Ltd.
  • Norgen BIoTek Corp.
  • Oxford Nanopore Technologies Limited
  • Rosetta Genomics Ltd.
  • Sigma Aldrich Corp.
  • System Biosciences, LLC
  • Thermo Fisher Scientific Inc.
  • TriLink BioTechnologies, Inc.
Product Code: MRR-02026C4C98C4

The microRNA Market was valued at USD 2.12 billion in 2023, expected to reach USD 2.72 billion in 2024, and is projected to grow at a CAGR of 28.84%, to USD 12.51 billion by 2030.

MicroRNAs (miRNAs) are small non-coding RNA molecules playing a crucial role in regulating gene expression, making them significant in various biological processes such as development, differentiation, apoptosis, and metabolism. The necessity of miRNA research stems from its potential applications in disease diagnostics, therapeutics, and personalized medicine, predominantly in oncology, cardiovascular diseases, and neurodegenerative disorders. The end-use of miRNAs encompasses pharmaceutical companies, academic and research institutions, and diagnostic centers. Key growth factors influencing the miRNA market include advancements in next-generation sequencing technologies, growing prevalence of chronic diseases, and increased funding in genomics research. The latest opportunities lie in the integration of miRNA with artificial intelligence for enhanced biomarker discovery and in developing miRNA-based therapeutics, specifically targeting genetic disorders and cancers. To leverage these opportunities, companies should invest in R&D for innovative delivery systems like nanotechnology and collaborate with academic institutions to accelerate discovery phases.

KEY MARKET STATISTICS
Base Year [2023] USD 2.12 billion
Estimated Year [2024] USD 2.72 billion
Forecast Year [2030] USD 12.51 billion
CAGR (%) 28.84%

However, the market faces limitations such as the complexity of miRNA biogenesis, delivery challenges in therapeutics, and stringent regulatory frameworks. Technical issues in sample handling and data variability also pose significant challenges. Forging ahead, innovation can be driven by developing robust multiplexing technologies for comprehensive miRNA profiling and improving computational tools for data analysis to enhance predictive modeling accuracy. Collaborations among stakeholders can further amplify research outputs and reduce time-to-market for new developments. The miRNA sector is dynamic and fast-evolving, demanding agile strategies and adaptability to regulatory changes and technological advances. Continuous monitoring of regulatory landscapes and fostering public-private partnerships can aid in overcoming growth challenges. Businesses should focus on building personalized medicine solutions and expanding the assay development for non-invasive diagnostics to stay competitive. Deploying translational research to bridge clinical gaps can also serve as a pivotal point for achieving long-term market potential and patient-centric outcomes.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving microRNA Market

The microRNA Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing incidence of chronic diseases and rising number of cancer cases
    • Growing importance of microRNA for the diagnosis of several diseases
    • Increasing research activities exploring the potential of microRNA globally
  • Market Restraints
    • High cost associated with microRNA kits and other products
  • Market Opportunities
    • Emerging microRNA tools for disease-associated analytical applications
    • Advancement in genomic studies and adoption of new tools for supporting research endeavors
  • Market Challenges
    • Safety and toxicity issues of microRNA

Porter's Five Forces: A Strategic Tool for Navigating the microRNA Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the microRNA Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the microRNA Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the microRNA Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the microRNA Market

A detailed market share analysis in the microRNA Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the microRNA Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the microRNA Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the microRNA Market

A strategic analysis of the microRNA Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the microRNA Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, Bio-Rad Laboratories, Inc., Global Life Sciences Solutions USA LLC, HTG Molecular Diagnostics, Inc., Illumina, Inc., Integrated DNA Technologies, Inc, Lexogen GmbH, Meridian Bioscience Inc, New England Biolabs (UK) Ltd., Norgen Biotek Corp., Oxford Nanopore Technologies Limited, Rosetta Genomics Ltd., Sigma Aldrich Corp., System Biosciences, LLC, Thermo Fisher Scientific Inc., and TriLink BioTechnologies, Inc..

Market Segmentation & Coverage

This research report categorizes the microRNA Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Assay Type, market is studied across Chemiluminescent Assays, Colorimetric Assays, Fluorescent Assays, Immunoassay, miRNA Arrays, Next-Generation Sequencing, and PCR-Based Assay.
  • Based on Product, market is studied across Consumables and Instruments.
  • Based on Services Type, market is studied across Functional Studies Services and Microarray Services.
  • Based on Application, market is studied across Cancer, Cardiovascular Disease, Immunological Disorder, Infectious Diseases, and Neurological Diseases.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidence of chronic diseases and rising number of cancer cases
      • 5.1.1.2. Growing importance of microRNA for the diagnosis of several diseases
      • 5.1.1.3. Increasing research activities exploring the potential of microRNA globally
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with microRNA kits and other products
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging microRNA tools for disease-associated analytical applications
      • 5.1.3.2. Advancement in genomic studies and adoption of new tools for supporting research endeavors
    • 5.1.4. Challenges
      • 5.1.4.1. Safety and toxicity issues of microRNA
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. microRNA Market, by Assay Type

  • 6.1. Introduction
  • 6.2. Chemiluminescent Assays
  • 6.3. Colorimetric Assays
  • 6.4. Fluorescent Assays
  • 6.5. Immunoassay
  • 6.6. miRNA Arrays
  • 6.7. Next-Generation Sequencing
  • 6.8. PCR-Based Assay

7. microRNA Market, by Product

  • 7.1. Introduction
  • 7.2. Consumables
  • 7.3. Instruments

8. microRNA Market, by Services Type

  • 8.1. Introduction
  • 8.2. Functional Studies Services
  • 8.3. Microarray Services

9. microRNA Market, by Application

  • 9.1. Introduction
  • 9.2. Cancer
  • 9.3. Cardiovascular Disease
  • 9.4. Immunological Disorder
  • 9.5. Infectious Diseases
  • 9.6. Neurological Diseases

10. Americas microRNA Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific microRNA Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa microRNA Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abcam PLC
  • 2. Bio-Rad Laboratories, Inc.
  • 3. Global Life Sciences Solutions USA LLC
  • 4. HTG Molecular Diagnostics, Inc.
  • 5. Illumina, Inc.
  • 6. Integrated DNA Technologies, Inc
  • 7. Lexogen GmbH
  • 8. Meridian Bioscience Inc
  • 9. New England Biolabs (UK) Ltd.
  • 10. Norgen Biotek Corp.
  • 11. Oxford Nanopore Technologies Limited
  • 12. Rosetta Genomics Ltd.
  • 13. Sigma Aldrich Corp.
  • 14. System Biosciences, LLC
  • 15. Thermo Fisher Scientific Inc.
  • 16. TriLink BioTechnologies, Inc.

LIST OF FIGURES

  • FIGURE 1. MICRORNA MARKET RESEARCH PROCESS
  • FIGURE 2. MICRORNA MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL MICRORNA MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL MICRORNA MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL MICRORNA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL MICRORNA MARKET SIZE, BY ASSAY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL MICRORNA MARKET SIZE, BY ASSAY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL MICRORNA MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL MICRORNA MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL MICRORNA MARKET SIZE, BY SERVICES TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL MICRORNA MARKET SIZE, BY SERVICES TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL MICRORNA MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL MICRORNA MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS MICRORNA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS MICRORNA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES MICRORNA MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES MICRORNA MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC MICRORNA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC MICRORNA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MICRORNA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA MICRORNA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. MICRORNA MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. MICRORNA MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. MICRORNA MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL MICRORNA MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MICRORNA MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL MICRORNA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. MICRORNA MARKET DYNAMICS
  • TABLE 7. GLOBAL MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL MICRORNA MARKET SIZE, BY CHEMILUMINESCENT ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL MICRORNA MARKET SIZE, BY COLORIMETRIC ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL MICRORNA MARKET SIZE, BY FLUORESCENT ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL MICRORNA MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL MICRORNA MARKET SIZE, BY MIRNA ARRAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL MICRORNA MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL MICRORNA MARKET SIZE, BY PCR-BASED ASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL MICRORNA MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL MICRORNA MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL MICRORNA MARKET SIZE, BY FUNCTIONAL STUDIES SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL MICRORNA MARKET SIZE, BY MICROARRAY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL MICRORNA MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL MICRORNA MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL MICRORNA MARKET SIZE, BY IMMUNOLOGICAL DISORDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL MICRORNA MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL MICRORNA MARKET SIZE, BY NEUROLOGICAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS MICRORNA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES MICRORNA MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC MICRORNA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. CHINA MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. CHINA MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. INDIA MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. INDIA MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. INDONESIA MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. INDONESIA MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. JAPAN MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. JAPAN MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. MALAYSIA MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. MALAYSIA MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. PHILIPPINES MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. PHILIPPINES MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. SINGAPORE MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SINGAPORE MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH KOREA MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SOUTH KOREA MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. TAIWAN MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. TAIWAN MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. THAILAND MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. THAILAND MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. VIETNAM MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. VIETNAM MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA MICRORNA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. DENMARK MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. DENMARK MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. EGYPT MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. EGYPT MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. FINLAND MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. FINLAND MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. FRANCE MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. FRANCE MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. GERMANY MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. GERMANY MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. ISRAEL MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. ISRAEL MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. ITALY MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. ITALY MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NETHERLANDS MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. NIGERIA MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. NIGERIA MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. NORWAY MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. NORWAY MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. POLAND MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. POLAND MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. QATAR MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. QATAR MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 161. RUSSIA MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. RUSSIA MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SAUDI ARABIA MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH AFRICA MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. SPAIN MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SPAIN MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. SWEDEN MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. SWEDEN MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. SWITZERLAND MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 185. TURKEY MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. TURKEY MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED ARAB EMIRATES MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED KINGDOM MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 195. MICRORNA MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 196. MICRORNA MARKET, FPNV POSITIONING MATRIX, 2023